Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 143.71B, Pfizer(PFE) trades at $25.31. The stock has a price-to-earnings ratio of 14.85 and currently yields dividends of 6.8%.
On 2026-01-13, Pfizer(PFE) stock moved within a range of $25.09 to $25.77. With shares now at $25.31, the stock is trading +0.9% above its intraday low and -1.8% below the session's peak.
Trading volume for Pfizer(PFE) stock has reached 50.26M, versus its average volume of 40.97M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
13:31 EST Pfizer (PFE) CEO says ‘not in our plans’ to do buybacks Claim 70% Off TipRanks Premium Published first on TheFly – the ultimate source for real-time...
13:06 EST Pfizer (PFE) CEO sees launching 10 Phase 3 GLP-1 trials this year Published first on TheFly – the ultimate source for real-time, market-moving breaki...
On Saturday, Pfizer Inc. (NYSE:PFE) shared data from Cohort 3 of the BREAKWATER trial. The Phase 3 BREAKWATER trial evaluated Braftovi (encorafenib) with cetux...
Analyst ratings
57%
of 28 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Study Overview This Phase 3 Pfizer study, officially tit...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...
Pfizer (PFE) is back in the oncology spotlight after reporting favorable Cohort 3 data from its pivotal BREAKWATER trial, where a regimen of BRAFTOVI, cetuximab...
It could be another tough year for the once-soaring drugmaker. Pfizer's (PFE +0.81%) shares have been southbound for the last three years. And unfortunately fo...
Madrigal Pharmaceuticals (MDGL) announced an exclusive global license agreement with Pfizer (PFE) for ervogastat, a clinical-stage oral DGAT-2 inhibitor, streng...
These high-yielding dividend stocks pay 5% or more, and make for safe income investments to hold on to. Dividend stocks can be the ultimate investments to buy...
If you are wondering whether Pfizer's current share price offers good value, this article will walk through what the latest data suggests and how to think about...